In addition, our finding that precancerous lesions but not pancreatic tumors express p16Ink4a and p19Arf in our mouse models (Fig. 2C) further argues that the checkpoint controlled by these proteins is lost late in pancreas carcinogenesis”. This evidence concerns the gene CDKN2A and pancreatic neoplasm.